Search
Categories
Hot topics close

Randomized Phase II Stereotactic Ablative Radiation Therapy for ...

Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI).

(UroToday.com) The 2023 American Society of Clinical Oncology (ASCO) annual meeting held in Chicago, IL between June 2nd and June 6th was host to a kidney and bladder cancers poster session. Dr. Rana McKay presented the rationale and study framework for SAMURAI, a randomized phase II trial evaluating stereotactic ablative radiation therapy (SABR) for patients with metastatic, unresected renal cell carcinoma (RCC) receiving systemic immunotherapy. Read More

News Archive
  • Ernst Young
    Ernst & Young
    Boots stock market float back on the table as £5bn sale collapses
    29 Jun 2022
    1
  • Neil Diamond
    Neil Diamond
    Review: ‘A Beautiful Noise’ Spotlights a Morose Neil Diamond
    7 Dec 2022
    2
  • C B I
    C B I
    CBI revises next year's economic growth forecast down to 5.1% | Confederation of British Industry (CBI) | The Guardian
    6 Dec 2021
    1
  • Vultures Kanye
    Vultures Kanye
    Kanye West & Ty Dolla $ign's 'Vultures 1' Album: All 16 Songs Ranked
    11 Feb 2024
    2
  • Silicon
    Silicon
    Silicon Power MS70 SSD-in-a-Stick Review: Thumb Drive Meets ...
    21 Dec 2023
    3
This week's most popular news